BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22944465)

  • 1. Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement.
    Ostrem JL; Galifianakis NB; Markun LC; Grace JK; Martin AJ; Starr PA; Larson PS
    Clin Neurol Neurosurg; 2013 Jun; 115(6):708-12. PubMed ID: 22944465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement.
    Bezchlibnyk YB; Sharma VD; Naik KB; Isbaine F; Gale JT; Cheng J; Triche SD; Miocinovic S; Buetefisch CM; Willie JT; Boulis NM; Factor SA; Wichmann T; DeLong MR; Gross RE
    J Neurosurg; 2020 Mar; 134(3):1072-1082. PubMed ID: 32114534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy.
    Starr PA; Martin AJ; Ostrem JL; Talke P; Levesque N; Larson PS
    J Neurosurg; 2010 Mar; 112(3):479-90. PubMed ID: 19681683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
    Mann JM; Foote KD; Garvan CW; Fernandez HH; Jacobson CE; Rodriguez RL; Haq IU; Siddiqui MS; Malaty IA; Morishita T; Hass CJ; Okun MS
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):794-7. PubMed ID: 19237386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion image-based programming after subthalamic nucleus deep brain stimulation.
    Paek SH; Kim HJ; Yoon JY; Heo JH; Kim C; Kim MR; Lim YH; Kim KR; Kim JW; Han JH; Kim DG; Jeon BS
    World Neurosurg; 2011; 75(3-4):517-24. PubMed ID: 21600506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease. Five years' personal experience.
    Zabek M; Sobstyl M; Koziara H; Kadziołka B; Mossakowski Z; Dzierzecki S
    Neurol Neurochir Pol; 2010; 44(1):3-12. PubMed ID: 20358480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
    Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
    Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of bilateral deep brain stimulation in the subthalamic nucleus using two methods of target structure verification].
    Goubareva NN; Fedorova NV; Bril' EV; Tomskiy AA; Gamaleya AA; Poddubskaya AA; Shabalov VA; Omarova SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):24-30. PubMed ID: 29265083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of 3T Magnetic Resonance Imaging for Targeting the Human Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease.
    Longhi M; Ricciardi G; Tommasi G; Nicolato A; Foroni R; Bertolasi L; Beltramello A; Moretto G; Tinazzi M; Gerosa M
    J Neurol Surg A Cent Eur Neurosurg; 2015 May; 76(3):181-9. PubMed ID: 25764475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients 'on medications'?
    Asha MJ; Kausar J; Krovvidi H; Shirley C; White A; Chelvarajah R; Hodson JA; Pall H; Mitchell RD
    Acta Neurochir (Wien); 2016 Feb; 158(2):387-93. PubMed ID: 26602236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative MRI for optimizing electrode placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease.
    Cui Z; Pan L; Song H; Xu X; Xu B; Yu X; Ling Z
    J Neurosurg; 2016 Jan; 124(1):62-9. PubMed ID: 26274983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
    Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
    J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.